Headache epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== | ||
The prevalence of cluster headache is approximately 3 to 150 per 100,000 individuals worldwide. | The prevalence of cluster headache is approximately 3 to 150 per 100,000 individuals worldwide.*Worldwide Prevalence of patient with secondary headache is approximately 18%. The prevalence of Migraine headache is estimated to be 12 to 15 percent of general population. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Revision as of 03:37, 8 April 2021
|
Headache Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Headache epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Headache epidemiology and demographics |
|
Risk calculators and risk factors for Headache epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
The prevalence of cluster headache is approximately 3 to 150 per 100,000 individuals worldwide.*Worldwide Prevalence of patient with secondary headache is approximately 18%. The prevalence of Migraine headache is estimated to be 12 to 15 percent of general population.
Epidemiology and Demographics
Prevalence
- The prevalence of cluster headache is approximately 3 to 150 per 100,000 individuals worldwide.[1]
- Worldwide Prevalence of patient with secondary headache is approximately 18%.[2]
- The prevalence of Migraine headache is estimated to be 12 to 15 percent of general population.[3]
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- Patients of all age groups may develop [disease name].
- The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
- [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
}
References
- ↑ Wei DY, Yuan Ong JJ, Goadsby PJ (2018). "Cluster Headache: Epidemiology, Pathophysiology, Clinical Features, and Diagnosis". Ann Indian Acad Neurol. 21 (Suppl 1): S3–S8. doi:10.4103/aian.AIAN_349_17. PMC 5909131. PMID 29720812.
- ↑ Do TP, Remmers A, Schytz HW, Schankin C, Nelson SE, Obermann M; et al. (2019). "Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list". Neurology. 92 (3): 134–144. doi:10.1212/WNL.0000000000006697. PMC 6340385. PMID 30587518.
- ↑ Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M (2001). "Prevalence and burden of migraine in the United States: data from the American Migraine Study II". Headache. 41 (7): 646–57. doi:10.1046/j.1526-4610.2001.041007646.x. PMID 11554952.